Virtu Financial’s Outlook Therapeutics OTLK Stock Holding History

Virtu Financial’s Portfolio OTLK Stock Details OTLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23K	Buy	+112,786	New	+$48.7K	﹤0.01%	1379
2024 Q2	–	Sell	-18,213	Closed	-$217K	–	1740
2024 Q1	$217K	Buy	18,213 +14,806	+435%	+$120K	0.02%	754
2023 Q4	$27K	Buy	+3,407	New	+$28.8K	﹤0.01%	1273
2023 Q1	–	Sell	-1,872	Closed	-$40K	–	1942
2022 Q4	$40K	Buy	+1,872	New	+$40.7K	0.01%	1120
2022 Q3	–	Sell	-1,056	Closed	-$22K	–	2101
2022 Q2	$22K	Buy	+1,056	New	+$30.4K	﹤0.01%	1313
2021 Q3	–	Sell	-707	Closed	-$35K	–	1833
2021 Q2	$35K	Sell	707 -161	-19%	-$7.47K	﹤0.01%	1378
2021 Q1	$39K	Sell	868 -4,679	-84%	-$179K	﹤0.01%	1458
2020 Q4	$144K	Buy	5,547 +4,506	+433%	+$94.2K	0.02%	957
2020 Q3	$15K	Buy	+1,041	New	+$23.2K	﹤0.01%	940
2019 Q4	$34K	Buy	2,893 +122	+4%	+$2.84K	﹤0.01%	1263
2019 Q3	$83K	Buy	+2,771	New	+$107K	0.01%	1119
2018 Q1	–	Sell	-177	Closed	-$37K	–	2413
2017 Q4	$37K	Sell	177 -5	-3%	-$1.04K	﹤0.01%	2125
2017 Q3	$40K	Buy	+182	New	+$33.1K	﹤0.01%	2258

Other funds holding OTLK

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $126M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NMC

Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Virtu Financial's OTLK Position: Q1 2026 in Review

Virtu Financial opened a new position in Outlook Therapeutics (OTLK) in Q1 2026: 112,786 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #1379 among its holdings. This is a return to the name: Virtu Financial previously reported a position in OTLK as recently as Q1 2024.

Virtu Financial first reported a position in OTLK in Q3 2017 and has held it in 13 quarters since. The position peaked at $217K in Q1 2024. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

Virtu Financial held 112,786 shares of Outlook Therapeutics worth $23K as of Q1 2026.
Outlook Therapeutics was a new Virtu Financial position in Q1 2026.
Outlook Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1379 holding.
Virtu Financial first reported a position in Outlook Therapeutics in Q3 2017 and has held it in 13 quarters since.
Virtu Financial's Outlook Therapeutics position peaked at $217K in Q1 2024.
54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.